Financial Performance - For the six months ended September 30, 2024, the group's revenue was approximately HKD 169.5 million, an increase of 45.3% compared to HKD 116.6 million for the same period in 2023[5]. - The net profit for the same period was approximately HKD 16.4 million, significantly up from HKD 1.5 million in the previous year, representing a growth of 1,093.3%[5]. - The company reported a basic earnings per share of HKD 2.05 for the period, compared to HKD 0.19 in the previous year, indicating a substantial increase[7]. - For the six months ending September 30, 2024, the company reported a pre-tax profit of HKD 16,430,000, compared to HKD 1,498,000 for the same period in 2023, indicating a significant increase in profitability[48]. - For the six months ended September 30, 2024, the company's revenue was approximately HKD 169.5 million, an increase of about HKD 52.9 million or 45.4% compared to the same period in 2023[73]. - Revenue from therapy services amounted to HKD 163,302,000, up from HKD 114,539,000 year-over-year, indicating a growth of about 42.5%[32]. Dividends and Equity - The board of directors did not recommend the distribution of dividends for the six months ended September 30, 2024, consistent with the previous year where no dividends were declared[5]. - The total equity of the company increased to approximately HKD 76.7 million from HKD 60.3 million, representing a growth of 27.2%[11]. - The board does not recommend the payment of an interim dividend for the six months ended September 30, 2024, consistent with the previous year[93]. Assets and Liabilities - Total assets as of September 30, 2024, were approximately HKD 153.8 million, up from HKD 111.8 million as of March 31, 2024, indicating a growth of 37.5%[9]. - The company's non-current assets increased to approximately HKD 135.6 million from HKD 96.6 million, marking a rise of 40.4%[9]. - Current liabilities increased to approximately HKD 128.6 million from HKD 111.5 million, reflecting a rise of 15.3%[11]. - The company has a net current liability of HKD 47,234,000, primarily due to contract liabilities of HKD 56,766,000, which are expected to generate cash inflows[27]. - Trade payables as of September 30, 2024, totaled HKD 3,786,000, compared to HKD 2,388,000 as of March 31, 2024, reflecting an increase of 58.6%[59]. Cash Flow and Investments - The net cash generated from operating activities for the six months ended September 30, 2024, was HKD 45,283,000, compared to HKD 6,967,000 in the previous year, reflecting a significant increase[18]. - The net cash used in investing activities was HKD (59,123,000) for the six months ended September 30, 2024, compared to HKD (826,000) in the previous year[19]. - Cash and cash equivalents decreased by HKD 7,613,000 during the period, resulting in a balance of HKD 11,696,000 as of September 30, 2024[21]. - The total cost of property, plant, and equipment purchased by the company for the six months ending September 30, 2024, was approximately HKD 41,023,000, compared to HKD 4,400,000 for the same period in 2023, showing a substantial increase in capital expenditure[49]. Operational Strategies - The company continues to focus on market expansion and product development strategies to sustain growth in the upcoming periods[5]. - The group opened several new centers in Tsim Sha Tsui, Central, and Causeway Bay to expand its operational scale, enhancing market penetration and profitability[72]. - The company continues to focus on expanding its therapy services and skincare product sales as part of its growth strategy[31]. - The company is actively implementing cost control measures and strategies to increase revenue, alongside discussions with banks for credit financing[27]. Employee and Costs - Total employee costs for the six months ending September 30, 2024, amounted to HKD 61,059,000, up from HKD 44,915,000 in the previous year, reflecting a year-over-year increase of approximately 36%[36]. - Employee costs for the six months ended September 30, 2024, were approximately HKD 61.1 million, up from HKD 44.9 million in the same period in 2023, primarily due to an increase in staff numbers[79]. - Marketing and promotional expenses for the six months ended September 30, 2024, were approximately HKD 17.9 million, compared to HKD 11.5 million in the same period in 2023, reflecting increased advertising activities[85]. Financial Management and Governance - The group has a strong commitment to financial risk management, closely collaborating with operational units to identify and mitigate financial risks[103]. - The company has maintained compliance with all applicable corporate governance rules as of September 30, 2024, ensuring shareholder rights and enhancing corporate value[108]. - The audit committee, consisting of three independent non-executive directors, reviewed the group's unaudited consolidated results for the six months ended September 30, 2024, confirming compliance with applicable accounting standards[111]. Other Financial Information - The company recognized right-of-use assets amounting to approximately HKD 18,397,000 for the six months ending September 30, 2024, compared to zero in the same period last year, indicating new asset acquisitions[49]. - The company’s total other income for the six months ending September 30, 2024, was HKD 267,000, compared to HKD 1,152,000 in the previous year, reflecting a decrease in other income sources[35]. - The group incurred capital expenditures of approximately HKD 41.0 million for the six months ended September 30, 2024, compared to HKD 4.4 million for the same period in 2023[92]. - The debt-to-equity ratio as of September 30, 2024, was calculated at 85.0%, an increase from 75.5% as of March 31, 2024[100].
亮晴控股(08603) - 2025 - 中期业绩